Liver inflammation is a risk factor for prediabetes in at-risk latinos with and without hepatitis C infection

Liver International

Volumn 35, Issue 1, 2015, Pages 101-107

  Burman, Blaire E ^a   Bacchetti, Peter ^a   Ayala, Claudia E ^a   Gelman, Nicholas ^a   Melgar, Jennifer ^a   Khalili, Mandana ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HCV; ALT; Hispanics; Impaired fasting glucose; Insulin resistance

Indexed keywords

ALANINE AMINOTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; GLUCOSE BLOOD LEVEL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL LABORATORY; CONTROLLED STUDY; ELEVATED BLOOD PRESSURE; FEMALE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HEPATITIS; HEPATITIS C; HIGH RISK POPULATION; HISPANIC; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; ORAL GLUCOSE TOLERANCE TEST; PROSPECTIVE STUDY; RISK FACTOR; VIRUS LOAD; COMPLICATION; ETHNOLOGY; GLUCOSE TOLERANCE TEST; METABOLISM; ODDS RATIO; PREDIABETIC STATE; STATISTICAL MODEL;

ADULT; BLOOD GLUCOSE; FEMALE; GLUCOSE TOLERANCE TEST; HEPATITIS; HEPATITIS C; HISPANIC AMERICANS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREDIABETIC STATE; RISK FACTORS;

EID: 84920983869     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12676     Document Type: Article

References (39)

1. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care 2006; 29: 1263-8.
2. Garber AJ, Handelsman Y, Einhorn D, et al. Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? Endocr Pract 2008; 14: 933-46.
3. Meigs JB, Muller DC, Nathan DM, Blake DR, Andres R. Baltimore longitudinal study of A. the natural history of progression from normal glucose tolerance to type 2 diabetes in the baltimore longitudinal study of aging. Diabetes 2003; 52: 1475-84.
4. Basu R, Barosa C, Jones J, et al. Pathogenesis of prediabetes: role of the liver in isolated fasting hyperglycemia and combined fasting and postprandial hyperglycemia. J Clin Endocrinol and Metabol 2013; 98: E409-17.
5. Nathan DM, Davidson MB, DeFronzo RA, et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007; 30: 753-9.
6. Mehta SH, Brancati FL, Sulkowski MS, et al. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000; 133: 592-9.
7. Jacobson IM, Cacoub P, Dal Maso L, Harrison SA, Younossi ZM. Manifestations of chronic hepatitis C virus infection beyond the liver. Clin Gastroenterol Hepatol 2010; 8: 1017-29.
8. Hui JM, Sud A, Farrell GC, et al. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]. Gastroenterology 2003; 125: 1695-704.
9. Aytug S, Reich D, Sapiro LE, Bernstein D, Begum N. Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes. Hepatology 2003; 38: 1384-92.
10. Mukhtar NA, Ayala C, Maher JJ, Khalili M. Assessment of factors associated with pre-diabetes in HCV infection including direct and dynamic measurements of insulin action. J Viral Hepatitis 2012; 19: 480-7.
11. Hanley AJ, Wagenknecht LE, Festa A, D'Agostino RB Jr, Haffner SM. Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: the Insulin resistance atherosclerosis study. Diabetes Care 2007; 30: 1819-27.
12. Milner KL, van der Poorten D, Trenell M, et al. Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance. Gastroenterology 2010; 138: e931-3.
13. Vozarova B, Stefan N, Lindsay RS, et al. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 2002; 51: 1889-95.
14. Montenegro L, De Michina A, Misciagna G, Guerra V, Di Leo A. Virus C hepatitis and type 2 Diabetes: a cohort study in southern Italy. Am J Gastroenterol 2013; 108: 1108-11.
15. Nguyen QM, Srinivasan SR, Xu JH, et al. Elevated liver function enzymes are related to the development of prediabetes and type 2 diabetes in younger adults: the Bogalusa Heart Study. Diabetes Care 2011; 34: 2603-7.
16. Petta S, Camma C, Di Marco V, et al. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection. Am J Gastroenterol 2008; 103: 1136-44.
17. Rodriguez-Torres M. Latinos and chronic hepatitis C: a singular population. Clin Gastroenterol Hepatol 2008; 6: 484-90.
18. Lorenzo C, Lee R, Haffner SM. Impaired glucose tolerance and obesity as effect modifiers of ethnic disparities of the progression to diabetes: the San Antonio Heart Study. Diabetes Care 2012; 35: 2548-52.
19. Lecube A, Hernandez C, Genesca J, Simo R. Glucose abnormalities in patients with hepatitis C virus infection: epidemiology and pathogenesis. Diabetes Care 2006; 29: 1140-9.
20. Huang JF, Yu ML, Dai CY, et al. Reappraisal of the characteristics of glucose abnormalities in patients with chronic hepatitis C infection. Am J Gastroenterol 2008; 103: 1933-40.
21. Bureau UC.Overview of race and hispanic origin. Available at: http://www.census.gov/prod/cen2010/briefs/c2010br-02.pdf Accessed: 1 May 2014.
22. Expert Committee on the D Classification of Diabetes M Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26(Suppl. 1): S5-20.
23. Lam KD, Bacchetti P, Abbasi F, et al. Comparison of surrogate and direct measurement of insulin resistance in chronic hepatitis C virus infection: impact of obesity and ethnicity. Hepatology 2010; 52: 38-46.
24. Yip J, Facchini FS, Reaven GM. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. The Journal of Clinical Endocrinology and Metabolism 1998; 83: 2773-6.
25. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement. Circulation 2009; 120: 1640-5.
26. Carrion AF, Ghanta R, Carrasquillo O, Martin P. Chronic liver disease in the Hispanic population of the United States. Clin Gastroenterol Hepatol 2011; 9: 834-41. quiz e109-810
27. Gonzalez Burchard E, Borrell LN, Choudhry S, et al. Latino populations: a unique opportunity for the study of race, genetics, and social environment in epidemiological research. Am J Public Health 2005; 95: 2161-8.
28. Karve A, Hayward RA. Prevalence, diagnosis, and treatment of impaired fasting glucose and impaired glucose tolerance in nondiabetic U.S. adults. Diabetes Care 2010; 33: 2355-9.
29. Mainous AG 3rd, Majeed A, Koopman RJ, et al. Acculturation and diabetes among Hispanics: evidence from the 1999-2002 National health and nutrition examination survey. Public Health Rep 2006; 121: 60-6.
30. Perez-Escamilla R, Putnik P. The role of acculturation in nutrition, lifestyle, and incidence of type 2 diabetes among Latinos. J Nutr 2007; 137: 860-70.
31. Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and pre-diabetes in the US population in 1988-1994 and 2005-2006. Diabetes Care 2009; 32: 287-94.
32. Bonnet F, Ducluzeau PH, Gastaldelli A, et al. Liver enzymes are associated with hepatic insulin resistance, insulin secretion, and glucagon concentration in healthy men and women. Diabetes 2011; 60: 1660-7.
33. Zhang Y, Lu X, Hong J, et al. Positive correlations of liver enzymes with metabolic syndrome including insulin resistance in newly diagnosed type 2 diabetes mellitus. Endocrine 2010; 38: 181-7.
34. Gao F, Pan JM, Hou XH, et al. Liver enzymes concentrations are closely related to prediabetes: findings of the Shanghai Diabetes Study II (SHDS II). Biomed Environ Sci 2012; 25: 30-7.
35. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Investig 2006; 116: 1793-801.
36. Michael MD, Kulkarni RN, Postic C, et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 2000; 6: 87-97.
37. Mehta SH, Brancati FL, Strathdee SA, et al. Hepatitis C virus infection and incident type 2 diabetes. Hepatology 2003; 38: 50-6.
38. Ruhl CE, Menke A, Cowie CC, Everhart JE. The Relationship of hepatitis C virus infection with diabetes in the United States Population. Hepatology 2014; doi: 10.1002/hep.27047. [Epub ahead of print].
39. Dufour MC. What is moderate drinking? Defining 'drinks' and drinking levels. Alcohol Res 1999; 23: 5-14.